Beauty Health Cash on Hand 2020-2025 | SKIN
Beauty Health cash on hand from 2020 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Beauty Health Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $370 |
| 2023 | $523 |
| 2022 | $568 |
| 2021 | $902 |
| 2020 | $9 |
| 2019 | $0 |
| Beauty Health Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $373 |
| 2024-12-31 | $370 |
| 2024-09-30 | $359 |
| 2024-06-30 | $350 |
| 2024-03-31 | $445 |
| 2023-12-31 | $523 |
| 2023-09-30 | $559 |
| 2023-06-30 | $550 |
| 2023-03-31 | $532 |
| 2022-12-31 | $568 |
| 2022-09-30 | $684 |
| 2022-06-30 | $821 |
| 2022-03-31 | $859 |
| 2021-12-31 | $902 |
| 2021-09-30 | $719 |
| 2021-06-30 | $101 |
| 2021-03-31 | $3 |
| 2020-12-31 | |
| 2020-09-30 | $0 |
| 2020-06-30 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.203B | $0.334B |
| The Beauty Health Company is a beauty health company. Its flagship brand HydraFacial is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp., is based in CHICAGO, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.314B | 25.57 |
| Elevance Health (ELV) | United States | $85.975B | 11.09 |
| CVS Health (CVS) | United States | $79.418B | 9.87 |
| Cencora (COR) | United States | $56.343B | 19.60 |
| DiDi Global (DIDIY) | China | $22.968B | 34.86 |
| Natera (NTRA) | United States | $21.581B | 0.00 |
| BioMerieux (BMXMF) | France | $15.705B | 0.00 |
| Solventum (SOLV) | United States | $12.562B | 13.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.357B | 0.00 |
| CochLear (CHEOY) | Australia | $11.324B | 0.00 |
| Revvity (RVTY) | United States | $10.833B | 18.64 |
| ICON (ICLR) | Ireland | $10.585B | 9.84 |
| Viatris (VTRS) | United States | $10.364B | 3.56 |
| Doximity (DOCS) | United States | $9.697B | 45.17 |
| Avantor (AVTR) | United States | $8.886B | 12.91 |
| HealthEquity (HQY) | United States | $8.734B | 42.97 |
| Medpace Holdings (MEDP) | United States | $8.538B | 22.68 |
| Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.763B | 13.25 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.142B | 24.42 |
| BrightSpring Health Services (BTSG) | United States | $4.077B | 37.74 |
| Sotera Health (SHC) | United States | $3.514B | 19.97 |
| Alignment Healthcare (ALHC) | United States | $2.948B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
| Concentras Parent (CON) | United States | $2.767B | 15.99 |
| Organon (OGN) | United States | $2.480B | 2.64 |
| Ardent Health Partners (ARDT) | United States | $2.103B | 8.96 |
| GeneDx Holdings (WGS) | United States | $1.997B | 76.90 |
| Premier (PINC) | United States | $1.891B | 14.36 |
| Progyny (PGNY) | United States | $1.829B | 40.26 |
| PACS (PACS) | United States | $1.513B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.361B | 27.21 |
| Teladoc Health (TDOC) | United States | $1.225B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.30 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.003B | 0.00 | |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| CareDx (CDNA) | United States | $0.922B | 14.40 |
| Nutex Health (NUTX) | United States | $0.921B | 13.91 |
| AMN Healthcare Services Inc (AMN) | United States | $0.807B | 7.56 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.611B | 4.12 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.523B | 43.04 |
| LifeMD (LFMD) | United States | $0.522B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.387B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.224B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| KindlyMD (NAKA) | United States | $0.135B | 0.00 |
| OncoCyte (OCX) | United States | $0.093B | 0.00 |
| So-Young (SY) | China | $0.093B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.069B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.048B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.019B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |